Andrew Rees

CEO Andrew Rees sells 32,688 shares across 3 transactions for $3,860,284.00 at Crocs; prior similar-ticker sales preceded 90d declines.

Andrew Rees, CEO of Crocs, executed 3 separate sales totaling 32,688 shares (32.7K shares) for $3,860,284.00 on 2026-06-05 at a blended average price of $118.09, reducing his holdings from 775,981 to 743,293 shares (a -4.2% reduction). This sale is noteworthy because his prior open-market sale at Crocs on 2024-06-17 was followed by a 90-day decline (-19.6%), and his cross-ticker track record shows 100% of prior sells were well-timed at the 90-day mark (avg 90d return -19.6%). The current price of $127.77 stands above the transaction price ($118.09), but the stock's rapid near-term momentum (+23.3% over 30 days, +58.9% over 90 days) follows the timing pattern observed in the CEO's prior exit. Investors should note that Crocs reported negative full-year net income in its most recent fiscal year despite current profitability in the latest quarter ($137.6M net income), providing a mixed fundamental backdrop against which to interpret the CEO's execution.

CEO Rees Andrew sells 10,000 CROX shares for $1.6M; prior 3 sells at ticker all well-timed with negative 90d returns.

Rees Andrew (Chief Executive Officer) sold 10,000 shares of Crox at $160.15 on 2024-06-17, reducing his holdings by 11.1% and realizing $1,601,507.00. This represents his fourth open-market sale of CROX stock; his prior 3 sales at this ticker (April 2023) were all well-timed at the 90-day mark, with subsequent declines of 18.2%, 9.5%, and 11.4% respectively, establishing a 3-of-3 pattern of sells followed by stock weakness. Across his full cross-ticker insider trading history, he has executed 3 prior sells with a 90-day well-timed rate of 100.00% and average 90-day returns of -13.0%, indicating consistent timing discipline. The current sale occurs at $160.15, just 0.2% below the 52-week high of $159.68, after the stock has appreciated 13.1% over 30 days and 13.9% over 90 days, setting up a comparable historical context for evaluation of post-sale price action.